| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Evotec AG | 36 | 3 | 4 | 0 | €25.43 | €26.00 | 2.241% |
| Bayer AG | 24 | 5 | 5 | 1 | €73.79 | €82.00 | 11.126% |
| Teva Pharmaceutical Industries Ltd ADR | 17 | 0 | 2 | 0 | €12.04 | €14.00 | 16.279% |
| Fresenius SE & Co. KGaA | 15 | 1 | 1 | 1 | €49.53 | €58.00 | 17.113% |
| Johnson & Johnson | 13 | 0 | 1 | 0 | €138.28 | €142.00 | 2.690% |
| Canopy Growth Corp | 13 | 1 | 1 | 0 | €20.12 | €38.00 | 88.867% |
| Morphosys AG | 12 | 0 | 3 | 0 | €113.90 | €124.50 | 9.306% |
| AbbVie Inc. | 12 | 0 | 3 | 0 | €87.80 | €97.00 | 10.478% |
| Aphria Inc. | 11 | 0 | 3 | 0 | €3.85 | €10.00 | 159.471% |
| Novo Nordisk A/S | 11 | 0 | 1 | 0 | €58.78 | €60.00 | 2.076% |
| Incyte Corp. | 9 | 0 | 1 | 0 | €74.55 | €105.70 | 41.782% |
| Bausch Health Companies Inc. | 9 | 0 | 1 | 0 | €24.00 | €32.40 | 35.000% |
| Spectrum Pharmaceuticals | 9 | 0 | 4 | 0 | €2.84 | €7.01 | 146.831% |
| Gilead Sciences Inc | 9 | 0 | 2 | 0 | €63.82 | €80.00 | 25.353% |
| UnitedHealth Group Inc. | 9 | 0 | 2 | 0 | €277.45 | €302.08 | 8.875% |
| Pfizer Inc. | 8 | 0 | 4 | 0 | €32.80 | €40.00 | 21.951% |
| Fresenius Medical Care AG & Co KGaA ST | 9 | 1 | 1 | 0 | €75.44 | €82.40 | 9.226% |
| Merck KGaA | 8 | 0 | 1 | 0 | €123.50 | €119.50 | -3.239% |
| Palatin Technologies | 9 | 1 | 0 | 0 | €0.56 | €2.00 | 259.454% |
| Bristol-Myers Squibb | 8 | 0 | 0 | 0 | €60.24 | €62.57 | 3.868% |
| Merck & Co. Inc. | 8 | 0 | 2 | 0 | €75.60 | €88.00 | 16.402% |
| Sangamo Bioscienes | 7 | 0 | 2 | 0 | €7.00 | €13.98 | 99.871% |
| Sarepta Therapeutics | 7 | 0 | 0 | 0 | €113.60 | €156.67 | 37.914% |
| QIAGEN NV | 9 | 2 | 2 | 0 | €34.50 | €37.88 | 9.809% |
| BB Biotech AG | 7 | 0 | 0 | 0 | - | €77.90 | - |
English
Deutsch